Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL‐2 receptor (DACLIZUMAB) on collagen‐induced arthritis (CIA) in rhesus monkeys

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical and Experimental Immunology

• Publication date

  2001-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2249.2001.01487.xPMID 11359452PMCID PMC1906026
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental immune mediated arthritis in rhesus monkeys

  2005cited by this paper
• Zenapax (daclizumab) reduces the incidence of acute rejection episodes and improves patient survival following renal transplantation. No 14874 and No 14393 Zenapax Study Groups.

  1999cited by this paper
• Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.

  1998cited by this paper
• Asymptomatic synovitis precedes clinically manifest arthritis.

  1998cited by this paper
• Collagen-induced arthritis in rhesus monkeys: evaluation of markers for inflammation and joint degradation.

  1998cited by this paper
• The relevance of arthritis research in non-human primates.

  1998cited by this paper
• Tranexamic acid, an inhibitor of plasminogen activation, reduces urinary collagen cross-link excretion in both experimental and rheumatoid arthritis.

  1998cited by this paper
• A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation.

  1997cited by this paper
• [Interleukin-2 receptor].

  1997cited by this paper
• Suppression of in vitro IgM rheumatoid factor production by diphtheria toxin interleukin 2 recombinant fusion protein (DAB 486IL-2) in patients with refractory rheumatoid arthritis.

  1996cited by this paper
• Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ.

  1996cited by this paper
• Urinary collagen crosslinks to monitor bone and cartilage degradation in collagen-induced arthritis in rhesus monkeys

  1995cited by this paper
• Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor.

  1994cited by this paper
• Restricted cytokine expression in rheumatoid arthritis.

  1993cited by this paper
• Resistance to collagen‐induced arthritis in rats and rhesus monkeys after immunization with attenuated type II collagen

  1993cited by this paper
• DAB486IL-2 fusion toxin in refractory rheumatoid arthritis.

  1993cited by this paper
• Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region

  1992cited by this paper
• Cloning of the gamma chain of the human IL-2 receptor.

  1992cited by this paper
• Immunohistologic study of T-cell receptor δ-chain expression in rheumatoid synovial membranes

  1992cited by this paper
• Immunohistologic study of T-cell receptor delta-chain expression in rheumatoid synovial membranes.

  1992cited by this paper
• Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival.

  1991cited by this paper
• A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.

  1991cited by this paper
• Collagen-induced arthritis in an outbred group of rhesus monkeys comprising responder and nonresponder animals. Relationship between the course of arthritis and collagen-specific immunity.

  1991cited by this paper
• Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys.

  1991cited by this paper
• The interleukin-2 receptor.

  1991cited by this paper
• Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.

  1990cited by this paper
• A humanized antibody that binds to the interleukin 2 receptor.

  1989cited by this paper
• Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.

  1989cited by this paper
• Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody.

  1989cited by this paper
• Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis

  1988cited by this paper
• Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.

  1986cited by this paper
• Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice

  1985cited by this paper
• [T cell growth factor].

  1984cited by this paper
• Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.

  1983cited by this paper
• A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

  1981cited by this paper
• T‐Cell Growth Factor

  1980cited by this paper

• J3ExoA: A Novel Anti-HIV Immunotoxin Fusion of Anti-Gp120 J3VHH and PE38 Fragment of Pseudomonas Exotoxin A

  2025cites this paper
• Identification of immunological characterization and Anoikis-related molecular clusters in rheumatoid arthritis

  2023cites this paper
• Advances in experimental models of rheumatoid arthritis

  2022cites this paper
• Signet-ring cell adenoma of the thyroid and rheumatoid arthritis: incidental association or methotrexate-related change?

  2017cites this paper
• Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program

  2016cites this paper
• SAFETY, BIODISTRIBUTION, AND EFFICACY OF AN AAV-5 VECTOR ENCODING HUMAN INTERFERON-BETA (ART-I02) DELIVERED VIA INTRA-ARTICULAR INJECTION IN RHESUS MONKEYS WITH COLLAGEN-INDUCED ARTHRITIS.

  2015cites this paper
• Safety, Biodistribution, and Efficacy of an AAV-5 Vector Encoding Human Interferon-Beta (ART-I02) Delivered via Intra-Articular Injection in Rhesus Monkeys with Collagen-Induced Arthritis

  2015cites this paper
• Gene therapy for arthritis: progress towards a clinical trial

  2015cites this paper
• The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis

  2015cites this paper
• Ginsenoside Metabolite Compound K Alleviates Adjuvant-Induced Arthritis by Suppressing T Cell Activation

  2014cites this paper
• Of Monkeys and Men: A Metabolomic Analysis of Static and Dynamic Urinary Metabolic Phenotypes in Two Species

  2014cites this paper
• Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.

  2014cites this paper
• Treatment of a mouse model of collagen antibody-induced arthritis with human adipose-derived secretions

  2013cites this paper
• Prevention Strategies for Type 1 Diabetes Mellitus

  2012cites this paper
• Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets

  2012cites this paper
• Cellular Targeting in Autoimmunity

  2012cites this paper
• New drug discovery strategies for rheumatoid arthritis: a niche for nonhuman primate models to address systemic complications in inflammatory arthritis

  2012cites this paper
• Mycophenolate mofetil and daclizumab targeting T lymphocytes in bleomycin‐induced experimental scleroderma

  2012cites this paper
• Spontaneous and Experimentally Induced Autoimmune Diseases in Nonhuman Primates

  2008cites this paper
• The significance of non-human primates as preclinical models of human arthritic disease

  2008cites this paper
• [Emerging therapy in rheumatoid arthritis].

  2008cites this paper
• What Animal Models are Best to Test Novel Rheumatoid Arthritis Therapies

  2008cites this paper
• Preclinical models of arthritic disease in non-human primates.

  2007cites this paper
• Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.

  2007cites this paper
• T regulatory cells: aid or hindrance in the clearance of disease?

  2007cites this paper
• Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody.

  2007cites this paper
• Anti-Tac (daclizumab, Zenapax) in the Treatment of Leukemia, Autoimmune Diseases, and in the Prevention of Allograft Rejection: A 25-Year Personal Odyssey

  2007cites this paper
• Utility of animal models for identification of potential therapeutics for rheumatoid arthritis

  2007cites this paper
• Sclerosis by a Human-Anti-Human IL-12 p 40 Nonhuman Primate Model of Multiple Suppression of Ongoing Disease in a

  2005cites this paper
• Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.

  2005cites this paper
• Suppression of Ongoing Disease in a Nonhuman Primate Model of Multiple Sclerosis by a Human-Anti-Human IL-12p40 Antibody1

  2005cites this paper
• Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5.

  2005cites this paper
• Non-human primate models of experimental autoimmune encephalomyelitis: Variations on a theme.

  2005cites this paper
• Cloning, sequencing and characterization of lentiviral-mediated expression of rhesus macaque (Macaca mulatta) interleukin-2 receptor alpha cDNA.

  2005cites this paper
• T cells and costimulatory factors in myasthenia gravis

  2005cites this paper
• Non-invasive measurement of brain damage in a primate model of multiple sclerosis.

  2004cites this paper
• 1H-NMR spectroscopy combined with pattern recognition analysis reveals characteristic chemical patterns in urines of MS patients and non-human primates with MS-like disease.

  2003cites this paper
• Streptococcal Cell Wall Induced Arthritis: Leukocyte Activation in Extra-Articular Lymphoid Tissue

  2003cites this paper
• Discovery and characterization of cooperative ligand binding in the adaptive region of interleukin-2.

  2003cites this paper
• Expression and characterization of the chemokine receptor CCR2B from rhesus monkey.

  2003cites this paper
• CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.

  2003cites this paper
• Gene therapy in nonhuman primate models of human autoimmune disease

  2003cites this paper
• Clinical advances in therapies targeting the interleukin-2 receptor.

  2003cites this paper
• Non-cancer therapeutic antibodies

  2002cites this paper
• Age‐related telomere length dynamics in peripheral blood mononuclear cells of healthy cynomolgus monkeys measured by Flow FISH

  2002cites this paper
• Serum Interleukin 2 Levels in Patients with Rheumatoid Arthritis and Correlation with Insulin Sensitivity

  2002cites this paper